http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CZ-2015633-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5fece74aa8c0cb73d997c194165159cc
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-096
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1652
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-096
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-40
filingDate 2015-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ec8aa8841bcb97b329d73f85839807bc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b2bfb4ce0eaebbaf0afa3fb3aaa5e636
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be0365371bc454ff7a621f0a0db2382f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c3a6ad487d0f6e9c0f8082101d045441
publicationDate 2017-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CZ-2015633-A3
titleOfInvention Amorphous form of vortioxetine hydrobromide stabilized by cyclodextrin
abstract The present invention relates to an amorphous vortioxetine hydrobromide stabilized by cyclodextrin as a suitable carrier, wherein the ratio of active pharmaceutical to cyclodextrin is 1: 4. Another object is a process for their preparation and use for a pharmaceutical composition.
priorityDate 2015-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444041
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419582371
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3014804
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453390375
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID260
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559198
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449846142
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87060060
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9966051
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452546838
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID56843850
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419495477

Total number of triples: 31.